These data suggest that LRRC52-AS1, LINC02082, and UNC5B-AS1 can be used to differentiate between benign and malignant tumors in thyroid nodules by measuring their expression levels, which has not been reported in PTC thus far. Here, LRRC52 is linked to cancer.